<DOC>
	<DOCNO>NCT01547910</DOCNO>
	<brief_summary>The aim study evaluate efficacy fish oil ( EPA/DHA ) child non-alcoholic fatty liver disease .</brief_summary>
	<brief_title>Effect Supplementation Fish Oil Non-alcoholic Fatty Liver Disease Children</brief_title>
	<detailed_description>76 child adolescent age 6-19 NAFLD include study . Diagnosis NAFLD set increase alanine transaminase feature liver steatosis ultrasound . Patients randomize receive either fish oil ( EPA/DHA , 400-1200mg ) placebo ( sunflower oil ) 6 month . All child advise reduce weight ( dietetic intervention + increase physical activity ) . Laboratory test , liver ultrasound , anthropometric analysis perform start , 3 month 6 month .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<criteria>age 619 overweight obesity ALT activity 130 % upper limit norm hyperechogenicity liver ultrasound HCV , HBV infection cholestasis chronic/acute liver failure alpha1antitrypsin deficiency Wilson disease type 2 diabetes mellitus betaoxidation defect alcohol consumption history parenteral nutrition use drug</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>19 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>fatty liver</keyword>
	<keyword>hepatitis</keyword>
	<keyword>insulin resistance</keyword>
	<keyword>unsaturated fatty acid</keyword>
	<keyword>NAFLD , child</keyword>
</DOC>